SC 13G: Annexon, Inc.
Ticker: ANNX · Form: SC 13G · Filed: Apr 22, 2024 · CIK: 1528115
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Annexon, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,052 words · 4 min read · ~4 pages · Grade level 8.8 · Accepted 2024-04-22 20:35:27
Key Financial Figures
- $0.001 — le of Class of Securities Common Stock, $0.001 par value 2(e) CUSIP Number 03589W102
Filing Documents
- d807203dsc13g.htm (SC 13G) — 50KB
- d807203dex99a.htm (EX-99.A) — 8KB
- 0001193125-24-105483.txt ( ) — 60KB
SIGNATURES
SIGNATURES After reasonable inquiry and the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BB Biotech AG Date: April 22, 2024 By: /s/ Martin Gubler Signatory Authority Name: Martin Gubler Title: Signatory Authority Date: April 22, 2024 By: /s/ Ivo Betschart Signatory Authority Name: Ivo Betschart Title: Signatory Authority Biotech Growth N.V. Date: April 22, 2024 By: /s/ Jan Bootsma Signatory Authority Name: Jan Bootsma Title: Signatory Authority Date: April 22, 2024 By: /s/ Hugo van Neutegem Signatory Authority Name: Hugo van Neutegem Title: Signatory Authority 7 of 8